Protease gene polymorphism and drug resistance related variation in HIV-1 infected patients having not received protease inhibitor therapy

LIU Li,LU Hong-zhou

DOI: https://doi.org/10.16150/j.1671-2870.2011.02.006

2011-01-01

Abstract:Objective To investigate the polymorphism of HIV-1 and the distribution of protease inhibitor resistance-associated diversity in human immunodeficiency virus-1(HIV-1) infected patients having not received protease inhibitor therapy.Methods HIV virus strains were taken from eighty-one HIV-1 infected patients having not received protease inhibitor therapy from four provinces/municipality(Shanghai,Anhui,Henan and Yunan) in China.Reverse transcription polymerase chain reaction was used to amplify the pol gene of HIV-1 and then it was sequenced and analyzed phylogenetically.Results The most prevalent HIV-1 was subtype B′(82.7%),followed by CRF01_AE(11%),CRF07_BC or CRF08_BC(3.7%),CRF02_AG(1.2%) and B(1.2%).The B′ subtype was mainly found in paid plasma blood donors and blood transfusion infected patients.Polymorphisms R41K,K70Q/R/E and L89M were more frequently found in non-B subtypes than in B/B′ subtypes.Minor drug resistance related variation I15M/V,K20M/R/I,M36I,H69K were more frequently found in non-B subtypes than in B′/B subtypes.However,minor drug resistance related variation I62V,L63P,A71V/T,V77I,I93L were more frequent in B/B′ subtypes than in non-B subtypes.Major drug resistance related variation M46I was found in 3 patients(3.7%) infected with B subtypes.Conclusions In HIV-1 infected patients having not received protease inhibitor therapy,the prevalences of gene polymorphism and minor drug resistance related variation are quite high while the prevalence of major drug resistance related variation is low.